Industry Research Reports

Home > Reports > Chemical & Material > Sirolimus API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Sirolimus API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-16

Pages: 145 Pages

Report ld: 3566188

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Sirolimus API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Sirolimus API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sirolimus API by region & country, by Type, and by Application.

The Sirolimus API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sirolimus API.

MARKET SEGMENTATION

By Company

Fuzhou Contay Biotechnology
Hangzhou Huadong Medicine Group Kangrun Pharmaceutical
Hangzhou Longshine Bio-Tech
Jiangsu Lianhuan Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
PKU Healthcare Chongqing DaXin Pharmaceutical
Chunghwa Chemical Synthesis & Biotech
ChemWerth Inc
ABRAXIS BIOSCIENCE
Abbott Laboratories
Aurisco Pharmaceutical
BrightGene Bio-Medical Technology
Concord Biotech
Murli Krishna Pharma
Orchestra Biomed
Partner Therapeutics
Selecta Biosciences
Wyeth Pharmaceuticals Inc

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

0.98
0.99
Others

Segment by Application

Tablets
Capsules
Oral Solution
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Sirolimus API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Sirolimus API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Sirolimus API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Sirolimus API Product Introduction

1.2 Global Sirolimus API Market Size Forecast

1.2.1 Global Sirolimus API Sales Value (2020-2031)

1.2.2 Global Sirolimus API Sales Volume (2020-2031)

1.2.3 Global Sirolimus API Sales Price (2020-2031)

1.3 Sirolimus API Market Trends & Drivers

1.3.1 Sirolimus API Industry Trends

1.3.2 Sirolimus API Market Drivers & Opportunity

1.3.3 Sirolimus API Market Challenges

1.3.4 Sirolimus API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Sirolimus API Players Revenue Ranking (2024)

2.2 Global Sirolimus API Revenue by Company (2020-2025)

2.3 Global Sirolimus API Players Sales Volume Ranking (2024)

2.4 Global Sirolimus API Sales Volume by Company Players (2020-2025)

2.5 Global Sirolimus API Average Price by Company (2020-2025)

2.6 Key Manufacturers Sirolimus API Manufacturing Base and Headquarters

2.7 Key Manufacturers Sirolimus API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Sirolimus API

2.9 Sirolimus API Market Competitive Analysis

2.9.1 Sirolimus API Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Sirolimus API Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sirolimus API as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 0.98

3.1.2 0.99

3.1.3 Others

3.2 Global Sirolimus API Sales Value by Type

3.2.1 Global Sirolimus API Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Sirolimus API Sales Value, by Type (2020-2031)

3.2.3 Global Sirolimus API Sales Value, by Type (%) (2020-2031)

3.3 Global Sirolimus API Sales Volume by Type

3.3.1 Global Sirolimus API Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Sirolimus API Sales Volume, by Type (2020-2031)

3.3.3 Global Sirolimus API Sales Volume, by Type (%) (2020-2031)

3.4 Global Sirolimus API Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Capsules

4.1.3 Oral Solution

4.1.4 Others

4.2 Global Sirolimus API Sales Value by Application

4.2.1 Global Sirolimus API Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Sirolimus API Sales Value, by Application (2020-2031)

4.2.3 Global Sirolimus API Sales Value, by Application (%) (2020-2031)

4.3 Global Sirolimus API Sales Volume by Application

4.3.1 Global Sirolimus API Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Sirolimus API Sales Volume, by Application (2020-2031)

4.3.3 Global Sirolimus API Sales Volume, by Application (%) (2020-2031)

4.4 Global Sirolimus API Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Sirolimus API Sales Value by Region

5.1.1 Global Sirolimus API Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Sirolimus API Sales Value by Region (2020-2025)

5.1.3 Global Sirolimus API Sales Value by Region (2026-2031)

5.1.4 Global Sirolimus API Sales Value by Region (%), (2020-2031)

5.2 Global Sirolimus API Sales Volume by Region

5.2.1 Global Sirolimus API Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Sirolimus API Sales Volume by Region (2020-2025)

5.2.3 Global Sirolimus API Sales Volume by Region (2026-2031)

5.2.4 Global Sirolimus API Sales Volume by Region (%), (2020-2031)

5.3 Global Sirolimus API Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Sirolimus API Sales Value, 2020-2031

5.4.2 North America Sirolimus API Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Sirolimus API Sales Value, 2020-2031

5.5.2 Europe Sirolimus API Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Sirolimus API Sales Value, 2020-2031

5.6.2 Asia Pacific Sirolimus API Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Sirolimus API Sales Value, 2020-2031

5.7.2 South America Sirolimus API Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Sirolimus API Sales Value, 2020-2031

5.8.2 Middle East & Africa Sirolimus API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Sirolimus API Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Sirolimus API Sales Value

6.2.1 Key Countries/Regions Sirolimus API Sales Value, 2020-2031

6.2.2 Key Countries/Regions Sirolimus API Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Sirolimus API Sales Value, 2020-2031

6.3.2 United States Sirolimus API Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Sirolimus API Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Sirolimus API Sales Value, 2020-2031

6.4.2 Europe Sirolimus API Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Sirolimus API Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Sirolimus API Sales Value, 2020-2031

6.5.2 China Sirolimus API Sales Value by Type (%), 2024 VS 2031

6.5.3 China Sirolimus API Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Sirolimus API Sales Value, 2020-2031

6.6.2 Japan Sirolimus API Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Sirolimus API Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Sirolimus API Sales Value, 2020-2031

6.7.2 South Korea Sirolimus API Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Sirolimus API Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Sirolimus API Sales Value, 2020-2031

6.8.2 Southeast Asia Sirolimus API Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Sirolimus API Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Sirolimus API Sales Value, 2020-2031

6.9.2 India Sirolimus API Sales Value by Type (%), 2024 VS 2031

6.9.3 India Sirolimus API Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Fuzhou Contay Biotechnology

7.1.1 Fuzhou Contay Biotechnology Company Information

7.1.2 Fuzhou Contay Biotechnology Introduction and Business Overview

7.1.3 Fuzhou Contay Biotechnology Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Fuzhou Contay Biotechnology Sirolimus API Product Offerings

7.1.5 Fuzhou Contay Biotechnology Recent Development

7.2 Hangzhou Huadong Medicine Group Kangrun Pharmaceutical

7.2.1 Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Company Information

7.2.2 Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Introduction and Business Overview

7.2.3 Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Sirolimus API Product Offerings

7.2.5 Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Recent Development

7.3 Hangzhou Longshine Bio-Tech

7.3.1 Hangzhou Longshine Bio-Tech Company Information

7.3.2 Hangzhou Longshine Bio-Tech Introduction and Business Overview

7.3.3 Hangzhou Longshine Bio-Tech Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Hangzhou Longshine Bio-Tech Sirolimus API Product Offerings

7.3.5 Hangzhou Longshine Bio-Tech Recent Development

7.4 Jiangsu Lianhuan Pharmaceutical

7.4.1 Jiangsu Lianhuan Pharmaceutical Company Information

7.4.2 Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview

7.4.3 Jiangsu Lianhuan Pharmaceutical Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Jiangsu Lianhuan Pharmaceutical Sirolimus API Product Offerings

7.4.5 Jiangsu Lianhuan Pharmaceutical Recent Development

7.5 Jiangsu Lianhuan Pharmaceutical

7.5.1 Jiangsu Lianhuan Pharmaceutical Company Information

7.5.2 Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview

7.5.3 Jiangsu Lianhuan Pharmaceutical Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Jiangsu Lianhuan Pharmaceutical Sirolimus API Product Offerings

7.5.5 Jiangsu Lianhuan Pharmaceutical Recent Development

7.6 PKU Healthcare Chongqing DaXin Pharmaceutical

7.6.1 PKU Healthcare Chongqing DaXin Pharmaceutical Company Information

7.6.2 PKU Healthcare Chongqing DaXin Pharmaceutical Introduction and Business Overview

7.6.3 PKU Healthcare Chongqing DaXin Pharmaceutical Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 PKU Healthcare Chongqing DaXin Pharmaceutical Sirolimus API Product Offerings

7.6.5 PKU Healthcare Chongqing DaXin Pharmaceutical Recent Development

7.7 Chunghwa Chemical Synthesis & Biotech

7.7.1 Chunghwa Chemical Synthesis & Biotech Company Information

7.7.2 Chunghwa Chemical Synthesis & Biotech Introduction and Business Overview

7.7.3 Chunghwa Chemical Synthesis & Biotech Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Chunghwa Chemical Synthesis & Biotech Sirolimus API Product Offerings

7.7.5 Chunghwa Chemical Synthesis & Biotech Recent Development

7.8 ChemWerth Inc

7.8.1 ChemWerth Inc Company Information

7.8.2 ChemWerth Inc Introduction and Business Overview

7.8.3 ChemWerth Inc Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 ChemWerth Inc Sirolimus API Product Offerings

7.8.5 ChemWerth Inc Recent Development

7.9 ABRAXIS BIOSCIENCE

7.9.1 ABRAXIS BIOSCIENCE Company Information

7.9.2 ABRAXIS BIOSCIENCE Introduction and Business Overview

7.9.3 ABRAXIS BIOSCIENCE Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 ABRAXIS BIOSCIENCE Sirolimus API Product Offerings

7.9.5 ABRAXIS BIOSCIENCE Recent Development

7.10 Abbott Laboratories

7.10.1 Abbott Laboratories Company Information

7.10.2 Abbott Laboratories Introduction and Business Overview

7.10.3 Abbott Laboratories Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Abbott Laboratories Sirolimus API Product Offerings

7.10.5 Abbott Laboratories Recent Development

7.11 Aurisco Pharmaceutical

7.11.1 Aurisco Pharmaceutical Company Information

7.11.2 Aurisco Pharmaceutical Introduction and Business Overview

7.11.3 Aurisco Pharmaceutical Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Aurisco Pharmaceutical Sirolimus API Product Offerings

7.11.5 Aurisco Pharmaceutical Recent Development

7.12 BrightGene Bio-Medical Technology

7.12.1 BrightGene Bio-Medical Technology Company Information

7.12.2 BrightGene Bio-Medical Technology Introduction and Business Overview

7.12.3 BrightGene Bio-Medical Technology Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 BrightGene Bio-Medical Technology Sirolimus API Product Offerings

7.12.5 BrightGene Bio-Medical Technology Recent Development

7.13 Concord Biotech

7.13.1 Concord Biotech Company Information

7.13.2 Concord Biotech Introduction and Business Overview

7.13.3 Concord Biotech Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Concord Biotech Sirolimus API Product Offerings

7.13.5 Concord Biotech Recent Development

7.14 Murli Krishna Pharma

7.14.1 Murli Krishna Pharma Company Information

7.14.2 Murli Krishna Pharma Introduction and Business Overview

7.14.3 Murli Krishna Pharma Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Murli Krishna Pharma Sirolimus API Product Offerings

7.14.5 Murli Krishna Pharma Recent Development

7.15 Orchestra Biomed

7.15.1 Orchestra Biomed Company Information

7.15.2 Orchestra Biomed Introduction and Business Overview

7.15.3 Orchestra Biomed Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.15.4 Orchestra Biomed Sirolimus API Product Offerings

7.15.5 Orchestra Biomed Recent Development

7.16 Partner Therapeutics

7.16.1 Partner Therapeutics Company Information

7.16.2 Partner Therapeutics Introduction and Business Overview

7.16.3 Partner Therapeutics Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.16.4 Partner Therapeutics Sirolimus API Product Offerings

7.16.5 Partner Therapeutics Recent Development

7.17 Selecta Biosciences

7.17.1 Selecta Biosciences Company Information

7.17.2 Selecta Biosciences Introduction and Business Overview

7.17.3 Selecta Biosciences Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.17.4 Selecta Biosciences Sirolimus API Product Offerings

7.17.5 Selecta Biosciences Recent Development

7.18 Wyeth Pharmaceuticals Inc

7.18.1 Wyeth Pharmaceuticals Inc Company Information

7.18.2 Wyeth Pharmaceuticals Inc Introduction and Business Overview

7.18.3 Wyeth Pharmaceuticals Inc Sirolimus API Sales, Revenue, Price and Gross Margin (2020-2025)

7.18.4 Wyeth Pharmaceuticals Inc Sirolimus API Product Offerings

7.18.5 Wyeth Pharmaceuticals Inc Recent Development

8 Industry Chain Analysis

8.1 Sirolimus API Industrial Chain

8.2 Sirolimus API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Sirolimus API Sales Model

8.5.2 Sales Channel

8.5.3 Sirolimus API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Sirolimus API Market Trends

Table 2. Sirolimus API Market Drivers & Opportunity

Table 3. Sirolimus API Market Challenges

Table 4. Sirolimus API Market Restraints

Table 5. Global Sirolimus API Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Sirolimus API Revenue Market Share by Company (2020-2025)

Table 7. Global Sirolimus API Sales Volume by Company (2020-2025) & (Tons)

Table 8. Global Sirolimus API Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Sirolimus API Price by Company (2020-2025) & (US$/Kg)

Table 10. Key Manufacturers Sirolimus API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Sirolimus API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Sirolimus API

Table 13. Global Sirolimus API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sirolimus API as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Sirolimus API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Sirolimus API Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Sirolimus API Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Sirolimus API Sales Market Share in Value by Type (2020-2025)

Table 20. Global Sirolimus API Sales Market Share in Value by Type (2026-2031)

Table 21. Global Sirolimus API Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Sirolimus API Sales Volume by Type (2020-2025) & (Tons)

Table 23. Global Sirolimus API Sales Volume by Type (2026-2031) & (Tons)

Table 24. Global Sirolimus API Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Sirolimus API Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Sirolimus API Price by Type (2020-2025) & (US$/Kg)

Table 27. Global Sirolimus API Price by Type (2026-2031) & (US$/Kg)

Table 28. Global Sirolimus API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Sirolimus API Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Sirolimus API Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Sirolimus API Sales Market Share in Value by Application (2020-2025)

Table 32. Global Sirolimus API Sales Market Share in Value by Application (2026-2031)

Table 33. Global Sirolimus API Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)

Table 34. Global Sirolimus API Sales Volume by Application (2020-2025) & (Tons)

Table 35. Global Sirolimus API Sales Volume by Application (2026-2031) & (Tons)

Table 36. Global Sirolimus API Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Sirolimus API Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Sirolimus API Price by Application (2020-2025) & (US$/Kg)

Table 39. Global Sirolimus API Price by Application (2026-2031) & (US$/Kg)

Table 40. Global Sirolimus API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Sirolimus API Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Sirolimus API Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Sirolimus API Sales Value by Region (2020-2025) & (%)

Table 44. Global Sirolimus API Sales Value by Region (2026-2031) & (%)

Table 45. Global Sirolimus API Sales Volume by Region (Tons): 2020 VS 2024 VS 2031

Table 46. Global Sirolimus API Sales Volume by Region (2020-2025) & (Tons)

Table 47. Global Sirolimus API Sales Volume by Region (2026-2031) & (Tons)

Table 48. Global Sirolimus API Sales Volume by Region (2020-2025) & (%)

Table 49. Global Sirolimus API Sales Volume by Region (2026-2031) & (%)

Table 50. Global Sirolimus API Average Price by Region (2020-2025) & (US$/Kg)

Table 51. Global Sirolimus API Average Price by Region (2026-2031) & (US$/Kg)

Table 52. Key Countries/Regions Sirolimus API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Sirolimus API Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Sirolimus API Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Sirolimus API Sales Volume, (2020-2025) & (Tons)

Table 56. Key Countries/Regions Sirolimus API Sales Volume, (2026-2031) & (Tons)

Table 57. Fuzhou Contay Biotechnology Company Information

Table 58. Fuzhou Contay Biotechnology Introduction and Business Overview

Table 59. Fuzhou Contay Biotechnology Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 60. Fuzhou Contay Biotechnology Sirolimus API Product Offerings

Table 61. Fuzhou Contay Biotechnology Recent Development

Table 62. Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Company Information

Table 63. Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Introduction and Business Overview

Table 64. Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 65. Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Sirolimus API Product Offerings

Table 66. Hangzhou Huadong Medicine Group Kangrun Pharmaceutical Recent Development

Table 67. Hangzhou Longshine Bio-Tech Company Information

Table 68. Hangzhou Longshine Bio-Tech Introduction and Business Overview

Table 69. Hangzhou Longshine Bio-Tech Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 70. Hangzhou Longshine Bio-Tech Sirolimus API Product Offerings

Table 71. Hangzhou Longshine Bio-Tech Recent Development

Table 72. Jiangsu Lianhuan Pharmaceutical Company Information

Table 73. Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview

Table 74. Jiangsu Lianhuan Pharmaceutical Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 75. Jiangsu Lianhuan Pharmaceutical Sirolimus API Product Offerings

Table 76. Jiangsu Lianhuan Pharmaceutical Recent Development

Table 77. Jiangsu Lianhuan Pharmaceutical Company Information

Table 78. Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview

Table 79. Jiangsu Lianhuan Pharmaceutical Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 80. Jiangsu Lianhuan Pharmaceutical Sirolimus API Product Offerings

Table 81. Jiangsu Lianhuan Pharmaceutical Recent Development

Table 82. PKU Healthcare Chongqing DaXin Pharmaceutical Company Information

Table 83. PKU Healthcare Chongqing DaXin Pharmaceutical Introduction and Business Overview

Table 84. PKU Healthcare Chongqing DaXin Pharmaceutical Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 85. PKU Healthcare Chongqing DaXin Pharmaceutical Sirolimus API Product Offerings

Table 86. PKU Healthcare Chongqing DaXin Pharmaceutical Recent Development

Table 87. Chunghwa Chemical Synthesis & Biotech Company Information

Table 88. Chunghwa Chemical Synthesis & Biotech Introduction and Business Overview

Table 89. Chunghwa Chemical Synthesis & Biotech Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 90. Chunghwa Chemical Synthesis & Biotech Sirolimus API Product Offerings

Table 91. Chunghwa Chemical Synthesis & Biotech Recent Development

Table 92. ChemWerth Inc Company Information

Table 93. ChemWerth Inc Introduction and Business Overview

Table 94. ChemWerth Inc Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 95. ChemWerth Inc Sirolimus API Product Offerings

Table 96. ChemWerth Inc Recent Development

Table 97. ABRAXIS BIOSCIENCE Company Information

Table 98. ABRAXIS BIOSCIENCE Introduction and Business Overview

Table 99. ABRAXIS BIOSCIENCE Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 100. ABRAXIS BIOSCIENCE Sirolimus API Product Offerings

Table 101. ABRAXIS BIOSCIENCE Recent Development

Table 102. Abbott Laboratories Company Information

Table 103. Abbott Laboratories Introduction and Business Overview

Table 104. Abbott Laboratories Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 105. Abbott Laboratories Sirolimus API Product Offerings

Table 106. Abbott Laboratories Recent Development

Table 107. Aurisco Pharmaceutical Company Information

Table 108. Aurisco Pharmaceutical Introduction and Business Overview

Table 109. Aurisco Pharmaceutical Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 110. Aurisco Pharmaceutical Sirolimus API Product Offerings

Table 111. Aurisco Pharmaceutical Recent Development

Table 112. BrightGene Bio-Medical Technology Company Information

Table 113. BrightGene Bio-Medical Technology Introduction and Business Overview

Table 114. BrightGene Bio-Medical Technology Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 115. BrightGene Bio-Medical Technology Sirolimus API Product Offerings

Table 116. BrightGene Bio-Medical Technology Recent Development

Table 117. Concord Biotech Company Information

Table 118. Concord Biotech Introduction and Business Overview

Table 119. Concord Biotech Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 120. Concord Biotech Sirolimus API Product Offerings

Table 121. Concord Biotech Recent Development

Table 122. Murli Krishna Pharma Company Information

Table 123. Murli Krishna Pharma Introduction and Business Overview

Table 124. Murli Krishna Pharma Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 125. Murli Krishna Pharma Sirolimus API Product Offerings

Table 126. Murli Krishna Pharma Recent Development

Table 127. Orchestra Biomed Company Information

Table 128. Orchestra Biomed Introduction and Business Overview

Table 129. Orchestra Biomed Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 130. Orchestra Biomed Sirolimus API Product Offerings

Table 131. Orchestra Biomed Recent Development

Table 132. Partner Therapeutics Company Information

Table 133. Partner Therapeutics Introduction and Business Overview

Table 134. Partner Therapeutics Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 135. Partner Therapeutics Sirolimus API Product Offerings

Table 136. Partner Therapeutics Recent Development

Table 137. Selecta Biosciences Company Information

Table 138. Selecta Biosciences Introduction and Business Overview

Table 139. Selecta Biosciences Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 140. Selecta Biosciences Sirolimus API Product Offerings

Table 141. Selecta Biosciences Recent Development

Table 142. Wyeth Pharmaceuticals Inc Company Information

Table 143. Wyeth Pharmaceuticals Inc Introduction and Business Overview

Table 144. Wyeth Pharmaceuticals Inc Sirolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 145. Wyeth Pharmaceuticals Inc Sirolimus API Product Offerings

Table 146. Wyeth Pharmaceuticals Inc Recent Development

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Sirolimus API Downstream Customers

Table 150. Sirolimus API Distributors List

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Sirolimus API Product Picture

Figure 2. Global Sirolimus API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Sirolimus API Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Sirolimus API Sales Volume (2020-2031) & (Tons)

Figure 5. Global Sirolimus API Sales Price (2020-2031) & (US$/Kg)

Figure 6. Sirolimus API Report Years Considered

Figure 7. Global Sirolimus API Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Sirolimus API Players Sales Volume Ranking (2024) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sirolimus API Revenue in 2024

Figure 10. Sirolimus API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 0.98 Picture

Figure 12. 0.99 Picture

Figure 13. Others Picture

Figure 14. Global Sirolimus API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Sirolimus API Sales Value Market Share by Type, 2024 & 2031

Figure 16. Global Sirolimus API Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)

Figure 17. Global Sirolimus API Sales Volume Market Share by Type, 2024 & 2031

Figure 18. Global Sirolimus API Price by Type (2020-2031) & (US$/Kg)

Figure 19. Product Picture of Tablets

Figure 20. Product Picture of Capsules

Figure 21. Product Picture of Oral Solution

Figure 22. Product Picture of Others

Figure 23. Global Sirolimus API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 24. Global Sirolimus API Sales Value Market Share by Application, 2024 & 2031

Figure 25. Global Sirolimus API Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)

Figure 26. Global Sirolimus API Sales Volume Market Share by Application, 2024 & 2031

Figure 27. Global Sirolimus API Price by Application (2020-2031) & (US$/Kg)

Figure 28. North America Sirolimus API Sales Value (2020-2031) & (US$ Million)

Figure 29. North America Sirolimus API Sales Value by Country (%), 2024 VS 2031

Figure 30. Europe Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 31. Europe Sirolimus API Sales Value by Country (%), 2024 VS 2031

Figure 32. Asia Pacific Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Sirolimus API Sales Value by Region (%), 2024 VS 2031

Figure 34. South America Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 35. South America Sirolimus API Sales Value by Country (%), 2024 VS 2031

Figure 36. Middle East & Africa Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 37. Middle East & Africa Sirolimus API Sales Value by Country (%), 2024 VS 2031

Figure 38. Key Countries/Regions Sirolimus API Sales Value (%), (2020-2031)

Figure 39. Key Countries/Regions Sirolimus API Sales Volume (%), (2020-2031)

Figure 40. United States Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 41. United States Sirolimus API Sales Value by Type (%), 2024 VS 2031

Figure 42. United States Sirolimus API Sales Value by Application (%), 2024 VS 2031

Figure 43. Europe Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 44. Europe Sirolimus API Sales Value by Type (%), 2024 VS 2031

Figure 45. Europe Sirolimus API Sales Value by Application (%), 2024 VS 2031

Figure 46. China Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 47. China Sirolimus API Sales Value by Type (%), 2024 VS 2031

Figure 48. China Sirolimus API Sales Value by Application (%), 2024 VS 2031

Figure 49. Japan Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 50. Japan Sirolimus API Sales Value by Type (%), 2024 VS 2031

Figure 51. Japan Sirolimus API Sales Value by Application (%), 2024 VS 2031

Figure 52. South Korea Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 53. South Korea Sirolimus API Sales Value by Type (%), 2024 VS 2031

Figure 54. South Korea Sirolimus API Sales Value by Application (%), 2024 VS 2031

Figure 55. Southeast Asia Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 56. Southeast Asia Sirolimus API Sales Value by Type (%), 2024 VS 2031

Figure 57. Southeast Asia Sirolimus API Sales Value by Application (%), 2024 VS 2031

Figure 58. India Sirolimus API Sales Value, (2020-2031) & (US$ Million)

Figure 59. India Sirolimus API Sales Value by Type (%), 2024 VS 2031

Figure 60. India Sirolimus API Sales Value by Application (%), 2024 VS 2031

Figure 61. Sirolimus API Industrial Chain

Figure 62. Sirolimus API Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Sirolimus API market? zhanKai

The top companies in the global Sirolimus API market are Fuzhou Contay Biotechnology、Hangzhou Huadong Medicine Group Kangrun Pharmaceutical、Hangzhou Longshine Bio-Tech.

Related Reports

Global Sirolimus API Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Sirolimus API market is projected to grow from US$ 236 million in 2025 to US$ 372 million by 2032, at a CAGR of 6.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-23
Pages: 168
USD 4900.00
(Single User License)
Global Sirolimus API Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Sirolimus API market size was US$ 236 million in 2025 and is forecast to reach a readjusted size of US$ 372 million by 2032 with a CAGR of 6.4% during the forecast period 2026-2032.
Published Date: 2026-08-23
Pages: 144
USD 4250.00
(Single User License)
Sirolimus API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sirolimus API was estimated to be worth US$ 236 million in 2025 and is projected to reach US$ 372 million, growing at a CAGR of 6.4% from 2026 to 2032.
Published Date: 2026-08-23
Pages: 141
USD 3950.00
(Single User License)
Global Sirolimus API Market Research Report 2026
The global Sirolimus API market was valued at US$ 236 million in 2025 and is anticipated to reach US$ 372 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
Published Date: 2026-08-23
Pages: 143
USD 2900.00
(Single User License)
Global Sirolimus API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sirolimus API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 104
USD 4250.00
(Single User License)
Global Sirolimus API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sirolimus API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 178
USD 4900.00
(Single User License)
Global Sirolimus API Market Research Report 2025
The global market for Sirolimus API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 115
USD 2900.00
(Single User License)
Global Sirolimus API Market Research Report 2024
The global Sirolimus API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-07
Pages: 117
USD 2900.00
(Single User License)

Global Sirolimus API Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Sirolimus API market is projected to grow from US$ 236 million in 2025 to US$ 372 million by 2032, at a CAGR of 6.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-23
Pages: 168
USD 4900.00 (Single User License)
Global Sirolimus API Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Sirolimus API market size was US$ 236 million in 2025 and is forecast to reach a readjusted size of US$ 372 million by 2032 with a CAGR of 6.4% during the forecast period 2026-2032.
Published: 2026-08-23
Pages: 144
USD 4250.00 (Single User License)
Sirolimus API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sirolimus API was estimated to be worth US$ 236 million in 2025 and is projected to reach US$ 372 million, growing at a CAGR of 6.4% from 2026 to 2032.
Published: 2026-08-23
Pages: 141
USD 3950.00 (Single User License)
Global Sirolimus API Market Research Report 2026
The global Sirolimus API market was valued at US$ 236 million in 2025 and is anticipated to reach US$ 372 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
Published: 2026-08-23
Pages: 143
USD 2900.00 (Single User License)
Global Sirolimus API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sirolimus API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 104
USD 4250.00 (Single User License)
Global Sirolimus API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sirolimus API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 178
USD 4900.00 (Single User License)
Global Sirolimus API Market Research Report 2025
The global market for Sirolimus API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 115
USD 2900.00 (Single User License)
Global Sirolimus API Market Research Report 2024
The global Sirolimus API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-07
Pages: 117
USD 2900.00 (Single User License)